(Q73230092)

English

[Secondary prevention of ischemic heart disease in the Cuidad Real Province, Spain. Effectiveness of lipid-lowering therapy in primary health care]

scientific article published on 01 September 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093891%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

[Secondary prevention of ischemic heart disease in the Cuidad Real Province, Spain. Effectiveness of lipid-lowering therapy in primary health care] (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093891%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Groupo de Investigation del estudio ELIPSE (El Estudio de Lípidos en Prevención Secundaria de Cardiopatía Isquémica)

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093891%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 September 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093891%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Medicina clínica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093891%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

115

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093891%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093891%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

321-325

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093891%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Prevention of coronary heart disease in clinical practice: a commentary on current treatment patterns in six European countries in relation to published recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Lipid lowering in a multidisciplinary clinic compared with primary physician management

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Secondary prevention in coronary heart disease: baseline survey of provision in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Time trend analysis and variations in prescribing lipid lowering drugs in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Management of hyperlipidaemia after coronary revascularisation: follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Current thinking in lipid lowering

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

New concepts and paradigms in cardiovascular medicine: the noninvasive management of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Low high-density lipoprotein cholesterol and what to do about it

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Cholesterol and coronary heart disease: predicting risks by levels and ratios

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Epidemiologic aspects of lipid abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Effects of combined bezafibrate-simvastatin appraised in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Persistence of use of lipid-lowering medications: a cross-national study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Forecasting patient outcomes in the management of hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

From trial data to practical knowledge: qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971546-6

7 January 2021

Identifiers

10.1016/S0025-7753(00)71546-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093891%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093891%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73230092&oldid=1740694242"